H. Meng
We are developing AI-based speech and language processing technologies for early detection of neurocognitive disorder (NCD, also known as dementia). The use of speech and language in NCD detection offers an accessible and affordable alternative to existing detection approaches, e.g. blood tests, brain scans, etc. We believe that the use of AI, as well as speech and language technologies, in digital health applications will be increasingly important for public health in our society.